Neoantigenic properties of TP53 variants modify cancer risk in individuals with Li-Fraumeni syndrome
Emilie Montellier, Olivier Manches, Jonathan Gaucher…·Pierre L. Hainaut
The paper analyzes how neoantigenic properties of TP53 variants correlate with cancer risk and presentation in Li-Fraumeni syndrome carriers.